Connect Sign In
Adam Barker, PhD, Named President and Chief Operations Officer of ARUP Reference Business Unit
In his new role, Adam Barker, PhD, will lead operational innovation to support ARUP’s growth while maintaining the highest quality.- December 23, 2025
- December 8, 2025
ARUP Experts Contributed to Castleman Disease Research Showcased by Recordati at ASH Annual Meeting
BRIDGEWATER, N.J.—Recordati Rare Diseases Inc. today announced the presentation of new data detailing advances in the understanding of Castleman disease (CD), a group of rare immune system disorders characterized by abnormal lymph node enlargement and systemic inflammatory symptoms that can be potentially life threatening.
- November 19, 2025
ARUP Advocates for the RESULTS Act To Protect Patient Access to Critical Laboratory Testing Services
The RESULTS Act offers meaningful reform to a flawed system and will ultimately benefit patients, support innovation, and create stability within the clinical laboratory community.- October 21, 2025
Journal of Clinical Microbiology Publishes Article on ARUP’s Validation of AI for Parasite Detection
An article describing ARUP’s validation of an artificial intelligence (AI) solution to detect gastrointestinal parasites in wet mounts has been published in the Journal of Clinical Microbiology.- September 15, 2025
ARUP Achieves Reaccreditation Under College of American Pathologists ISO 15189 Program
ARUP is the largest lab to receive reaccreditation under the updated ISO 15189 standard, an achievement that highlights the company’s technical excellence, commitment to quality, and innovation.- April 21, 2025
ARUP Launches pTau 217 Blood Test To Detect Alzheimer’s Disease Pathology
ARUP Laboratories now offers a test for pTau 217 to aid in the detection of Alzheimer’s disease pathology. This test is minimally invasive and more accessible than other types of diagnostic testing.- March 31, 2025
ARUP Applauds Federal Court Decision Vacating the FDA’s Final Rule Regulating Lab-Developed Tests
The rule and its compliance deadlines are no longer in effect, benefiting patient care, innovation, and the greater laboratory community, ARUP leaders said.- March 11, 2025
Pramana, Inc., and ARUP are collaborating to improve the assessment of bone marrow biopsies and address other key diagnostic challenges in hematopathology.- March 6, 2025
ARUP Laboratories Expands AI-Augmented Parasitology Screening Tool, Improves Detection and Diagnosis
ARUP will expand its AI-augmented screening tool for the detection of human gastrointestinal parasites to become first and only lab to apply AI to the entire ova and parasite testing process.- February 3, 2025
The partnership combines Tasso’s clinical grade blood collection solutions and ARUP’s gold standard testing capabilities to streamline and accelerate decentralized clinical research.- January 3, 2025
ARUP has launched a new assay for the detection and subtyping of influenza A (H5) virus, which will expand the national capacity to detect the current outbreak of highly pathogenic avian influenza A (H5N1).- October 21, 2024
Augurex Announces Agreement With ARUP To Expand Access to Advanced Rheumatoid Arthritis Diagnosis
ARUP Laboratories is partnering with Augurex Life Sciences Corp. to include the 14-3-3η test in the ARUP test menu to enhance the early detection of rheumatoid arthritis. - November 19, 2025
